Literature DB >> 25456652

Polycystic ovarian syndrome.

Subbulaxmi Trikudanathan1.   

Abstract

Women with PCOS present with signs of chronic anovulation, hyperandrogenism, and metabolic abnormalities. The NIH recently embraced the Rotterdam criteria to broadly identify all the phenotypes of PCOS. Women with PCOS are often obese with insulin resistance and hence have an increased susceptibility to glucose intolerance and type 2 diabetes. Future research should focus on the genetic, epigenetic, and environmental determinants of PCOS to develop new therapies to address the prevention of this disorder and its long-term complications.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anovulation; Hyperandrogenism; Infertility; Insulin resistance; Polycystic ovarian syndrome; Type 2 diabetes

Mesh：

Substances：

Year:  2014        PMID： 25456652     DOI： 10.1016/j.mcna.2014.09.003

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  23 in total

1.  3D ultrasound findings in women attending a South Australian recurrent miscarriage clinic.

Authors:  Catherine D McCormack; Denise L Furness; Gustaaf A Dekker; Karen Shand; Claire T Roberts
Journal:  Australas J Ultrasound Med       Date:  2016-10-28

2.  Prevalence and associated risk factors for mental health problems among patients with polycystic ovary syndrome in Bangladesh: A nationwide cross-Sectional study.

Authors:  Moynul Hasan; Sumaya Sultana; Md Sohan; Shahnaj Parvin; Md Ashrafur Rahman; Md Jamal Hossain; Mohammad Saydur Rahman; Md Rabiul Islam
Journal:  PLoS One       Date:  2022-06-22       Impact factor: 3.752

3.  Polycystic Ovarian Syndrome Genetics and Epigenetics.

Authors:  Joshua C Combs; Micah J Hill; Alan H Decherney
Journal:  Clin Obstet Gynecol       Date:  2021-03-01       Impact factor: 1.966

4.  Epigenetic modification of long interspersed elements-1 in cumulus cells of mature and immature oocytes from patients with polycystic ovary syndrome.

Authors:  Kamthorn Pruksananonda; Artisa Wasinarom; Wisan Sereepapong; Porntip Sirayapiwat; Prakasit Rattanatanyong; Apiwat Mutirangura
Journal:  Clin Exp Reprod Med       Date:  2016-06-23

5.  A Network Pharmacology Approach to Explore the Pharmacological Mechanism of Xiaoyao Powder on Anovulatory Infertility.

Authors:  Huiping Liu; Liuting Zeng; Kailin Yang; Guomin Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-12-18       Impact factor: 2.629

6.  Successful pregnancy after mucinous cystic neoplasm with invasive carcinoma of the pancreas in a patient with polycystic ovarian syndrome: a case report.

Authors:  Conisha Holloman; S J Carlan; Lohini Sundharkrishnan; Angela Guzman; Mario Madruga
Journal:  J Med Case Rep       Date:  2017-07-11

7.  Inhibition of microRNA-19b promotes ovarian granulosa cell proliferation by targeting IGF-1 in polycystic ovary syndrome.

Authors:  Zhuohui Zhong; Fang Li; Yingying Li; Shuang Qin; Canliang Wen; Yiyuan Fu; Qing Xiao
Journal:  Mol Med Rep       Date:  2018-01-22       Impact factor: 2.952

8.  A randomized, controlled trial comparing the metformin, oral contraceptive pills and their combination in patients with polycystic ovarian syndrome.

Authors:  Yogesh Kumar; Narendra Kotwal; Yashpal Singh; Vimal Upreti; Shrikant Somani; K V S Hari Kumar
Journal:  J Family Med Prim Care       Date:  2018 May-Jun

9.  Genome-wide association study for SNPs associated with PCOS in human patients.

Authors:  Li Chen; Ling-Min Hu; Yu-Feng Wang; Hai-Yan Yang; Xiao-Yang Huang; Wei Zhou; Hai-Xiang Sun
Journal:  Exp Ther Med       Date:  2017-09-07       Impact factor: 2.447

10.  MiR-23a induced the activation of CDC42/PAK1 pathway and cell cycle arrest in human cov434 cells by targeting FGD4.

Authors:  Ji Lin; Huijuan Huang; Liheng Lin; Weiwei Li; Jianfen Huang
Journal:  J Ovarian Res       Date:  2020-08-09       Impact factor: 4.234
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.